CIK 0001671584 · Non-accelerated filer<br>Smaller reporting company
Aptevo Therapeutics Inc.
Sign in to watch- Ticker
- APVO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811567056
- Phone
- 206-838-0500
- Business address
- 2401 4TH AVE., SUITE 1050, SEATTLE, WA, 98121
- 8-K Event Other events
- 424B5 Offering Prospectus
- 8-K Event Material agreement
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Other events
- 4 Option exercise President and CEO acquired 4,792 shares (option exercise)
- 4 Option exercise SVP and CFO acquired 1,833 shares (option exercise)
- 8-K Event Executive or director change · Regulation FD disclosure
- 4 Other acquisition Director acquired 124,999 shares (other)
- 4 Open-market sale Exit Filing sold 921,336 shares at an average $11.25 ($10,368,236)
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Other events
- SC 13D/A Stake Beneficial Ownership Report
- 4 Open-market sale 10% owner sold 838,664 shares at an average $7.75 ($6,500,411)
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · Shareholder rights changed
- 8-K Event Executive or director change
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
Page 20 of 38 · 743 filings